1. Home
  2. EXEL vs SSB Comparison

EXEL vs SSB Comparison

Compare EXEL & SSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • SSB
  • Stock Information
  • Founded
  • EXEL 1994
  • SSB 1933
  • Country
  • EXEL United States
  • SSB United States
  • Employees
  • EXEL N/A
  • SSB N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • SSB Major Banks
  • Sector
  • EXEL Health Care
  • SSB Finance
  • Exchange
  • EXEL Nasdaq
  • SSB Nasdaq
  • Market Cap
  • EXEL 11.1B
  • SSB 9.0B
  • IPO Year
  • EXEL 2000
  • SSB 1997
  • Fundamental
  • Price
  • EXEL $42.64
  • SSB $86.88
  • Analyst Decision
  • EXEL Buy
  • SSB Strong Buy
  • Analyst Count
  • EXEL 24
  • SSB 12
  • Target Price
  • EXEL $44.73
  • SSB $115.64
  • AVG Volume (30 Days)
  • EXEL 3.3M
  • SSB 913.8K
  • Earning Date
  • EXEL 11-04-2025
  • SSB 10-22-2025
  • Dividend Yield
  • EXEL N/A
  • SSB 2.70%
  • EPS Growth
  • EXEL 53.55
  • SSB 12.25
  • EPS
  • EXEL 2.38
  • SSB 7.27
  • Revenue
  • EXEL $2,288,218,000.00
  • SSB $2,324,984,000.00
  • Revenue This Year
  • EXEL $9.14
  • SSB $57.84
  • Revenue Next Year
  • EXEL $12.51
  • SSB $3.76
  • P/E Ratio
  • EXEL $17.53
  • SSB $12.22
  • Revenue Growth
  • EXEL 9.93
  • SSB 39.42
  • 52 Week Low
  • EXEL $31.90
  • SSB $77.74
  • 52 Week High
  • EXEL $49.62
  • SSB $114.27
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 60.50
  • SSB 33.71
  • Support Level
  • EXEL $41.23
  • SSB $86.00
  • Resistance Level
  • EXEL $43.72
  • SSB $90.50
  • Average True Range (ATR)
  • EXEL 1.47
  • SSB 1.70
  • MACD
  • EXEL 0.34
  • SSB 0.25
  • Stochastic Oscillator
  • EXEL 84.72
  • SSB 16.67

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About SSB SouthState Corporation

SouthState Bank Corp is a United States-based bank holding company. It provides a wide range of services and products to its customers through a wholly-owned bank subsidiary. The Bank provides retail and commercial banking services, mortgage lending services, trust and investment services, and consumer finance loans through financial centers in Alabama, Florida, Georgia, North Carolina, South Carolina, and Virginia. These services include demand, time and savings deposits, lending and credit card servicing, ATM processing, and wealth management and trust services.

Share on Social Networks: